Long-term pulmonary function in survivors of childhood Hodgkin disease and non-Hodgkin lymphoma

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 699-703

  Oguz, Aynur ^a   Tayfun, Tayyar ^a   Citak, Elvan Caglar ^a,b   Karadeniz, Ceyda ^a   Tatlicioglu, Turkan ^a   Boyunaga, Oznur ^a   Bora, Huseyin ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Children; Hodgkin disease; Late effects; Non Hodgkin lymphoma; Pulmonary function test

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBON MONOXIDE; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CHRONIC DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HODGKIN DISEASE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT DISEASE; RISK REDUCTION; SMOKING HABIT; SPIROMETRY; SYMPTOMATOLOGY; AGE; LUNG; PATHOPHYSIOLOGY; RADIOTHERAPY; RISK FACTOR; SURVIVOR;

AGE FACTORS; ANTINEOPLASTIC AGENTS; HODGKIN DISEASE; HUMANS; LUNG; LYMPHOMA, NON-HODGKIN; RADIOTHERAPY; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SURVIVORS;

EID: 35148818344     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21175     Document Type: Article

References (29)

1. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 2001;13:242-248.
2. Movsas B, Raffin TA, Epstein AH, et al. Pulmonary radiation injury. Chest 1997;111:1061-1076.
3. Attard-Montalto SP, Kingston JE, Eden OB, et al. Late follow-up of lung function after whole lung irradiation for Wilm's tumor. Br J Radiol 1992;65:1114-1118.
4. Fryer CJ, Fitzpatric PJ, Rider WD, et al. Radiation pneumonitis: Experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys 1978;4:931-936.
5. Jakacki RI, Schramm CM, Donahue BR, et al. Restrictive lung disease following treatment for malignant brain tumor: A potential late effect of craniospinal irradiation.J Clin Oncol 1995;13:1478-1485.
6. Ginsberg SJ, Comis RL. The pulmonary toxicity of antineoplastic agents. Semin Oncol 1982;9:34-51.
7. Fauroux B, Meyer-Milsztain A, Boccon-Gibod L, et al. Cytotoxic drug-induced pulmonary disease in infants and children. Pediatr Pulmonol 1994;18:347-355.
8. Shapiro SJ, Shapiro SD, Mill WB, et al. Prospective study of long-term manifestations of mantle irradiation. Int J Radiat Oncol Biol Phys 1990;19:707-714.
9. Watchie J, Coleman CN, Raffin TA, et al. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1987;13:517-524.
10. Lund MB, Kongerud J, Nome O, et al. Lung function impairment in long-term survivors of Hodgkin's disease. Ann Oncol 1995;6:495-501.
11. Villani F, Viviani S, Bonfante V, et al. Late pulmonary effects in favorable stage I and IIA Hodgkin's disease treated with radiotherapy alone. Am J Clin Oncol 2000;23:18-21.
12. Villaini F, De Maria P, Bonfante V, et al. Late pulmonary toxicity after treatment for Hodgkin's disease. Anticancer Res 1997;17:4739-4742.
13. Gustavsson A, Eskilsson J, Landberg T, et al. Long-term effects on pulmonary function of mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1992;3:455-461.
14. Hassink EA, Souren TS, Boersma LJ, et al. Pulmonary morbidity 10-18 years after irradiation of Hodgkin's disease. Eur J Cancer 1993;29A:343-347.
15. Ilhan I, Sarialioglu F, Bilgic H, et al. Long-term pulmonary function in children with Hodgkin's disease. Acta Paediatr 1996;85:324-326.
16. Mefferd JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: Pulmonary, cardiac and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 1989;16:679-685.
17. Makipernaa A, Heino M, Laitinen LA, et al. Lung function following treatment of malignant tumor with surgery, radiotherapy, or cyclophosphamide in childhood. A follow-up study after 11 to 27 years. Cancer 1989;63:625-630.
18. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. Cancer 2002: 95; 2431-2441.
19. ATS, American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
20. Report Working Party. Standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratotry Society. Eur Respir J 1993;6:3-52.
21. Pellegrino R, Viegi G, Brusasco V, et al. Series ATS/ERS Task Force: Standardization of lung function testing. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-968.
22. American Thoracic Society. Lung function testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-1218.
23. Morris AH, Kanner RE, Crapo RO, et al. (eds). Clinical pulmonary function testing: A manual of uniform laboratory procedures, 2nd edition. Salt Lake City: Intermountain Thoracic Society; 1984.
24. Cosset JM, Henry Amar H, Thomas J, et al. Increased pulmonary toxicity in the ABVD arm of the EORTCH6V Trial. J Clin Oncol 1989;8A:985.
25. Dopico GA, Wiley AL, Rao P, et al. Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease. Chest 1979;75:688-692.
26. Nysom K, Holm K, Hertz H, et al. Risk factors for reduced pulmonary function after malignant lymphoma in childhood. Med Pediatr Oncol 1998;30:240-248.
27. Huber A, Gutjahr P, Kleinheisterkamp U. Lung function following irradiation in pediatric cancer patients. Dtsch Med Wolchenschr 1989;114:1367-1370.
28. Boersma LJ, Damen EMF, de Boer RW, et al. Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. J Clin Oncol 1996;14:1431-1441.
29. Leupold W, Ronisch P, Hahn B. The effect of radio- and chemotherapy on lung function in children with malignant disease. Pneumologie 1990;44:1213-1216.